CfxA-1

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290.......300.......310.......320. MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNKSQASQYVAHISAVVYSLLMQTSVKS

CfxA-2	.......................................................................................................................................................................................................................................................................................................E.........................	99.69 %
CfxA-3	..................................................................................................................................................................................................................................................................D....................................E.........................	99.38 %
CfxA-4	..................................................................................................................................................................................................................................................................N....................................E.........................	99.38 %
CfxA-5	..................................................................................................................................................................................................................................................................C....................................E.........................	99.38 %
CfxA-6	.................................G......................................................................................................................................V..............................................................................................................................E.........................	99.07 %
CfxA-7	...............................................................................................G.......................................................................................................................................................................................................E.........................	99.38 %
CfxA-8	.......................................................................................................................................................................................K..........................W....................................................................................E.........................	99.07 %
CfxA-9	..............................................................................................................................................................................................................V........................................................................................E.........................	99.38 %
CfxA-10	....................................................................................................................................................................................................................................F.............................D....................................E.........................	99.07 %
CfxA-11	........................................................................A..........................................................................................................................................V...................................................................................E.........................	99.07 %

Last updated: September 18, 2025.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since March 29th, 2025)